Meyka AI API is live for developers.Start building.
Advertisement
Innovent Biologics, Inc.

Innovent Biologics, Inc. (IVBXF) Stock Overview

Explore Innovent Biologics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

IVBXF●PNK
HealthcareBiotechnology
$9.10
$0.00(0.00%)
U.S. Market opens in 6h 16m
Advertisement

Innovent Biologics, Inc. (IVBXF)

Meyka AI Score

Z

Key Financials

Market Cap15.8B
P/E Ratio68.84
EPS (TTM)$0.07
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$10.46
3 Months$13.87
1 Year Target$16.42

IVBXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Innovent Biologics, Inc. (IVBXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 68.84 and a market capitalization of 15.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-6.95%
1-Month Change
-11.65%
3-Month Change
-13.33%
6-Month Change
-17.27%
Year-to-Date (YTD) Change
-6.67%
1-Year Change
-10.17%
3-Year Change
90.38%
5-Year Change
-18.09%
All-Time (Max) Change
188.49%

Contact Information

https://www.innoventbio.com
86 512 6956 6088
168 Dongping Street, Suzhou, NaN, 215123

Company Facts

5,659 Employees
IPO DateSep 4, 2019
CountryCN
Actively Trading

Frequently Asked Questions